Methodology of personalised invitation of Czech citizens to the Czech Programme for Colorectal Cancer Screening

Czech version

Authors: L. Dušek ¹; O. Májek ¹; M. Bláha ¹; Š. Suchánek ²; B. Seifert ³; M. Zavoral ²
Authors‘ workplace: Institut biostatistiky a analýz, MU, Brno ¹; Interní klinika 1. LF UK a ÚVN – VFN, Praha3 Ústav všeobecného lékařství, 1. LF UK, Praha ²
Published in: Gastroent Hepatol 2013; 67(5): 342-347
Category: Gastrointestinal Oncology: Review Article

Overview

Colorectal cancer is a preventable disease and its mortality and incidence rate can be significantly reduced by an organised screening programme. The Czech screening programme has sufficient capacity, is guaranteed by a wide spectrum of medical specialites and disposes of an information system compatible with international standards. A fundamental prerequisite to fulfil the screening programme objectives, i.e. reduction of incidence and mortality, is sufficient attendance of the target population, i.e. men and women over 50 years old. One of the key interventions in this field is personalised invitations to the screening examination. This article provides an overview of studies and publications that present a successful implementation of personalised invitations to the colorectal cancer screening. The methodology of personalised invitations proposed for the Czech screening programme and criteria for inclusion or exclusion of a particular client in/from the screening programme are also described.

Key words:
colorectal cancer – prevention – screening – personalised invitation

The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.

The Editorial Board declares that the manuscript met the ICMJE „uniform requirements“ for biomedical papers.

Submitted:
8. 9. 2013

Accepted:
7. 10. 2013

Sources

1. Ferlay J, Shin HR, Bray F et al. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [online]. Lyon, France: International Agency for Research on Cancer 2010. Available from: http://globocan.iarc.fr.

2. Dušek L, Mužík J, Kubásek M et al. Epidemiologie zhoubných nádorů v České republice [online]. Brno: Masarykova univerzita 2005. Dostupné z: http://www.svod.cz.

3. Dušek L (ed.). Czech cancer care in numbers 2008–2009. Praha: Grada Publishing 2009.

4. Pavlík T, Májek O, Mužík J et al. Estimating the number of colorectal cancer patients treated with anti-tumour therapy in 2015: the analysis of the Czech National Cancer Registry. BMC Public Health 2012; 12: 117.

5. Bond JH. Fecal occult blood testing for colorectal cancer. Can we afford not to do this? Gastroenterol Cin North Am 1997; 26(1): 57–70.

6. Hewitson P, Glasziou P, Watson E et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008; 103(6): 1541–1549.

7. Brenner H, Hoffmeister M, Brenner G et al. Expected reduction of colorectal cancer incidence within 8 years after introduction of the German screening colonoscopy programme: estimates based on 1,875,708 screening colonoscopies. Eur J Cancer 2009; 45(11): 2027–2033.

8. Zauber AG, Winawer SJ, O'Brien MJ et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012; 366(8): 687–696.

9. Zavoral M, Suchánek Š, Májek O et al. Populační screening kolorektálního karcinomu v České republice. Rozhl Chir 2009; 88(6): 292–294.

10. Frič P, Zavoral M. Screening kolorektálního karcinomu: projekce zahraničních zkušeností – jak se lze poučit, jak dále? Prakt Lék 2002; 82(4): 203–204.

11. Zavoral M, Suchanek S, Zavada F et al. Colorectal cancer screening in Europe. World J Gastroenterol 2009; 15(47): 5907–5915.

12. Council Recommendation of 2 December 2003 on cancer screening. Official Journal of the European Union 2003; 16: 34–39.

13. Poc P, Brepoels F, Busoi CS et al. Written declaration on fighting colorectal cancer in the European Union. The European Parliament 2010. Available from: http://www.ueg.eu/fileadmin/user_upload/documents/News/WrittenDeclaratioon.68.2010.ENG.pdf.

14. Karsa L, Anttila A, Ronco G et al. Cancer Screening in the European Union: Report on the implementation of the Council Recommendation on cancer screening. Luxembourg: European Communities 2008.

15. Prorok PC, Kramer BS, Gohagan JK. Screening theory and study design: the basics. In: Kramer BS, Gohagan JK, Prorok PC (eds). Cancer Screening: Theory and Practice. New York: CRC Press 1999.

16. Segnan N, Patnick J, von Karsa L. European guidelines for quality assurance in colorectal cancer screening and diagnosis. Luxembourg: Publications Office of the European Union 2010.

17. Miles A, Cockburn J, Smith RA et al. A perspective from countries using organized screening programs. Cancer 2004; 101 (5 Suppl): 1201–1213.

18. Májek O, Danes J, Zavoral M et al. Czech national cancer screening programmes in 2010. Klin Onkol 2010; 23(5): 343–353.

19. Weller D, Coleman D, Robertson R et al. The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer 2007; 97(12): 1601–1605.

20. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ 2004; 329(7458): 133.

21. Denis B, Ruetsch M, Strentz P et al. Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test. Gut 2007; 56(11): 1579–1584.

22. Hol L, van Leerdam ME, van Ballegooijen M et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010; 59(1): 62–68.

23. Steele RJ, McClements PL, Libby G et al. Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Gut 2009; 58(4): 530–535.

24. Peris M, Espinàs JA, Muñoz L et al. Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain). J Med Screen 2007; 14(2): 81–86.

25. Logan RF, Patnick J, Nickerson C et al. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut 2012; 61(10): 1439–1446.

26. Malila N, Palva T, Malminiemi O et al. Coverage and performance of colorectal cancer screening with the faecal occult blood test in Finland. J Med Screen 2011; 18(1): 18–23.

27. Malila N, Oivanen T, Malminiemi O et al. Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design. BMJ 2008; 337: a2261.

28. Malila N, Anttila A, Hakama M. Colorectal cancer screening in Finland: details of the national screening programme implemented in Autumn 2004. J Med Screen 2005; 12(1): 28–32.